指南与共识造血干细胞移植与细胞治疗MDS 与骨髓增殖性肿瘤

骨髓纤维化异基因造血干细胞移植:移植物失败、移植物功能不良与复发的定义及管理策略:EBMT慢性恶性肿瘤工作组最佳实践建议

Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party.
指南 / 共识 · Leukemia · 2021-05-26

该建议由EBMT慢性恶性肿瘤工作组实践协调与指南小组组织国际专家组制定,针对骨髓纤维化异基因造血干细胞移植后的移植物失败、移植物功能不良和复发提出实用且临床相关的定义及管理策略,并建议系统开展分子学监测、组织病理学评估和嵌合体检测,以提高报告准确性和一致性。

要点

  • 提出移植物失败、移植物功能不良和复发的临床相关定义。
  • 建议系统开展分子学监测、组织病理学评估和嵌合体检测。
  • 回顾性研究中复发率介于15%至25%,管理策略差异大。

核心结论

  • 该建议旨在提高报告准确性和一致性,并促进针对移植后并发症形成更一致的管理方法。

研究设计与样本

  • EBMT慢性恶性肿瘤工作组实践协调与指南小组召集由移植血液学家、组织病理学家和分子生物学家组成的国际专家组制定建议。

主要发现

  • 回顾性研究中复发率介于15%至25%,管理策略从姑息治疗到过继免疫治疗乃至二次异基因造血干细胞移植不等。
  • 异基因造血干细胞移植后因脾肿大和不利的「促炎性」骨髓微环境,移植物功能不良和移植物失败发生率较高。

关键数值与推荐

  • 提出移植物失败、移植物功能不良和复发的实用且临床相关定义。
  • 建议系统开展分子学监测、组织病理学评估和嵌合体检测。

临床怎么用

  • 建议对骨髓纤维化异基因造血干细胞移植后患者系统开展分子学监测、组织病理学评估和嵌合体检测。
  • 建议依据所提出的定义识别移植物失败、移植物功能不良和复发,并参考所提管理策略进行处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Allogeneic haematopoietic cell transplantation (allo-HCT) remains the only curative approach in myelofibrosis (MF). Despite advances over recent decades, relapse and non-relapse mortality rates remain significant. Relapse rates vary between 15 and 25% across retrospective studies and management strategies vary widely, ranging from palliation to adoptive immunotherapy and, in some cases, a second allo-HCT. Moreover, in allo-HCT, there is a higher incidence of poor graft function and graft failure due to splenomegaly and a hostile "pro-inflammatory" marrow niche. The Practice Harmonisation and Guidelines subcommittee of the Chronic Malignancies Working Party (CMWP) of EBMT convened an international panel consisting of transplant haematologists, histopathologists and molecular biologists to propose practical, clinically relevant definitions of graft failure, poor graft function and relapse as well as management strategies following allo-HCT. A systematic approach to molecular monitoring, histopathological assessment and chimerism testing is proposed. These proposed recommendations aim to increase the accuracy and uniformity of reporting and to thereby facilitate the development of more consistent approaches to these challenging issues. In addition, we propose management strategies for these complications.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. McLornan DP, Hernandez-Boluda JC, Czerw T, et al. Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party. Leukemia. 2021. PMID: 34040148. doi:10.1038/s41375-021-01294-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。